Team

Executive Team
Board of Directors
Investors
Advisory Board
Quality Reporting
Registry Solutions

Mike Doyle
President and CEO

Michael Zalis, MD
Co-Founder and Chief Medical Officer

Carl Berke
Partner, Partners Innovation Fund
Carl’s career has spanned over 25 years in the practice and management of innovation to bring new technologies from lab to market. He has been an active private equity investor as a member of Angel Healthcare Investors LLC and is a founder of Mass Medical Angels. He has served on the boards of Quosa, Kasalis, Combinent, Infobionic and the Sudanese Education Fund. Carl holds an AB degree from Cornell University and received his PhD in Organic Chemistry from the University of California at Berkeley. He also holds an appointment as Lecturer in the Biomedical Enterprise Program in the Harvard-MIT Division of Health Sciences and Technology. Carl currently represents the Fund on the Boards of Annovation, Sebacia and QPID Health.

Philippe Chambon
Managing Director, New Leaf Venture Partners
Philippe Chambon is a Managing Director and concentrates on information convergence and biopharmaceutical investments. He joined the Sprout Group in 1995 and became a General Partner in 1997 before becoming one of the founders of New Leaf in 2005. Over his career, he has invested broadly in healthcare technology companies across multiple sectors and stages of development. Philippe served as Manager in the Healthcare Practice of The Boston Consulting Group from 1993 to 1995. From 1987 to 1993, he was an executive with Sandoz Pharmaceutical, where he led strategic product development, portfolio management and pre-marketing activities in his capacity as Executive Director of New Product Management. Philippe did graduate research in molecular immunology at The Pasteur Institute and earned a M.D., Ph.D. from the University of Paris. Philippe also has an M.B.A. from Columbia University in New York.

Brandon Hull
Managing General Partner, Cardinal Partners
Brandon Hull is a co-founder of Cardinal Partners, a medical and life sciences venture capital partnership established in 1996. His investment experience began in 1991 and includes all facets of health care services, medical products and devices, but he has particular range and expertise in healthcare information technology and technology-enabled-services. Brandon spent seven years in health services operations previously, and has served on the boards of numerous healthcare and medical technology companies, spanning the landscape of the healthcare economy, from insurers and managed care payers, inpatient and outpatient providers, and consumer health markets. Past and present board seats include athenahealth (ATHN), Visicu (Phillips Medical), CodeRyte (3M), Fluidnet, Novalis (Trizetto), Awarepoint and QPID Health. Brandon received his BA from Wheaton College (Chicago) and his MBA from The Wharton School at the University of Pennsylvania.

Stan Reiss

General Partner, Matrix Partners
Stan Reiss is passionate about bringing cutting edge technology to market. Since joining Matrix over a decade ago, he has invested primarily in companies developing technically sophisticated components, systems, and software, including healthcare information technology.  His investments include Acacia Communications, Fastback Networks, QPID Health, Qualtre, and Xtalic. Stan received a bachelor’s degree in electrical engineering at Cornell University, two engineering masters’ degrees from MIT (focused on communications networking), and an MBA from the Harvard Business School (where he was a Baker Scholar).

QPID Technology

Cardinal Partners
Since 1996, Cardinal Partners has been one of the leading venture capital partnerships focused exclusively on healthcare investing. Cardinal specializes in early stage financing rounds, usually as the lead investor in the initial financing round of a growth company. Cardinal’s investors include university endowments, foundations, pension funds, banks, and insurance companies. Cardinal currently manages funds totaling $400 Million.

Massachusetts General Physicians Organization
The Massachusetts General Physicians Organization (MGPO) is a multi-specialty medical group dedicated to excellence and innovation in patient care, teaching and research.

Matrix Partners
Matrix Partners is a premier venture capital firm that has generated outstanding returns for more than three decades. By focusing on early-stage investments and emphasizing long-term relationships with entrepreneurs, the firm has delivered several of the industry’s top performing funds of all time. Matrix Partners has offices in Cambridge and Waltham, MA; Palo Alto, CA; Mumbai, India; and Beijing and Shanghai, China. Matrix Partners has invested in several game-changing, industry-leading businesses such as Apple Computer, Aruba, HubSpot, JBoss, Netezza, Phone.com, Polyvore, Starent Networks, Tivoli Systems, Veritas, Zendesk, and Zong.

New Leaf Venture Partners
New Leaf Venture Partners is a leading healthcare technology venture firm.  We invest broadly across healthcare-related information technology companies as well as both public and private biopharmaceutical companies. New Leaf currently manages two funds: New Leaf Ventures I, L.P., and New Leaf Ventures II, L.P. (NLV-II), as well as the healthcare technology portfolio of the Sprout Group, one of the oldest U.S. venture capital fund groups.  New Leaf’s current active fund, NLV-II, has committed $80 million to companies in the healthcare IT sector and $270 million to firms in the biopharmaceutical sector.  For more information please visit http://www.nlvpartners.com.

Partners Innovation Fund
The Partners Innovation Fund, established in 2007, was launched with a total commitment of $35 million from Brigham and Women’s Hospital and Massachusetts General Hospital. It addresses Partners HealthCare’s unmet need for funding of early-stage technology to drive improved medical care for patients.

QPID Technology

David W. Bates, MD, MSc, Chief of the Division of General Internal Medicine and Primary Care at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical School, and Professor of Health Policy and Management at the Harvard School of Public Health.

Alan Ezekowitz, MBChB, D.Phil., FAAP, Co-Founder, President and CEO of Abide Therapeutics

John D. Halamka, MD, MS, a Professor of Medicine at Harvard Medical School and Chief Information Officer of Beth Israel Deaconess Medical Center.

Julia Adler-Milstein, PhD, an Assistant Professor at University of Michigan whose research focuses on policy and management issues related to the use of IT in healthcare delivery.

John E. Osborn, JD, MIPP, a senior advisor with the international law firm Hogan Lovells, executive in residence with the healthcare group of Warburg Pincus, a regular contributor to Forbes.com and a faculty member at the University of Washington, Seattle.

Robert M. Wachter, MD, a Professor of Medicine at the University of California, San Francisco (UCSF), Associate Chairman of UCSF’s Department of Medicine, and Chief of UCSF’s 60-faculty Division of Hospital Medicine.